Articles with "endpoints clinical" as a keyword



Photo by gyanoba from unsplash

Some remaining challenges regarding multiple endpoints in clinical trials.

Sign Up to like & get
recommendations!
Published in 2017 at "Statistics in medicine"

DOI: 10.1002/sim.7390

Abstract: Despite recent advance in methods for handling multiple endpoints in clinical trials, some challenges remain. This paper discusses some of these challenges, including confusion surrounding the terminology used to describe the multiple endpoints, the justification… read more here.

Keywords: regarding multiple; endpoints clinical; challenges regarding; clinical trials ... See more keywords
Photo by cdc from unsplash

Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease.

Sign Up to like & get
recommendations!
Published in 2019 at "Statistics in medicine"

DOI: 10.1002/sim.8282

Abstract: In March of 2018, the National Kidney Foundation, in collaboration with the US Food and Drug Administration and the European Medicines Agency, sponsored a workshop in which surrogate endpoints other than currently established event-time endpoints… read more here.

Keywords: kidney; slope based; endpoints clinical; clinical trials ... See more keywords
Photo from archive.org

Design and Endpoints of Clinical Trials, Current and Future

Sign Up to like & get
recommendations!
Published in 2019 at "Digestive Diseases and Sciences"

DOI: 10.1007/s10620-019-05541-6

Abstract: With the advent of several new systemic agents for the treatment of hepatocellular carcinoma and the prospect of more to come it is expected that many more clinical trials will be undertaken to establish the… read more here.

Keywords: trials current; current future; endpoints clinical; clinical trials ... See more keywords
Photo by nappystudio from unsplash

Imaging endpoints for clinical trial use: a RECIST perspective

Sign Up to like & get
recommendations!
Published in 2022 at "Journal for Immunotherapy of Cancer"

DOI: 10.1136/jitc-2022-005092

Abstract: Twenty years after its initial introduction, Response Evaluation Criteria in Solid Tumors (RECIST) remains today a unique standardized tool allowing uniform objective evaluation of response in solid tumors in clinical trials across different treatment indications.… read more here.

Keywords: trial use; recist; clinical trial; imaging endpoints ... See more keywords
Photo by impulsq from unsplash

Endpoints for Clinical Trials of Acute Kidney Injury

Sign Up to like & get
recommendations!
Published in 2018 at "Nephron"

DOI: 10.1159/000493203

Abstract: Background: The selection of appropriate endpoints is critical to the success of any clinical trial. Endpoints need to be precisely defined and need to provide an appropriate balance between sensitivity for detection of the effects… read more here.

Keywords: acute kidney; endpoints clinical; clinical trials; kidney injury ... See more keywords